Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

Abbafati, Cristiana

Autores:: Abbafati, Cristiana
Abbas, Kaja M.
Abbasi, Mohammad
Abbasifard, Mitra
Abbasi-Kangevari, Mohsen
Abbastabar, Hedayat
Abd-Allah, Foad
Abdelalim, Ahmed
Abdollahi, Mohammad
Abdollahpour, Ibrahim

Tipo de recurso:: Article of journal

Fecha de publicación:: 2020

Institución:: Corporación Universidad de la Costa

Repositorio:: REDICUC - Repositorio CUC

Idioma:: eng

id	RCUC2_92ff57b3c328572ed255f9f688fc9e80
oai_identifier_str	oai:repositorio.cuc.edu.co:11323/7832
network_acronym_str	RCUC2
network_name_str	REDICUC - Repositorio CUC
repository_id_str
dc.title.spa.fl_str_mv	Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
title	Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
spellingShingle	Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 Risk-factors Clinical-trials Prevention Disability Dementia Falls
title_short	Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
title_full	Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
title_fullStr	Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
title_full_unstemmed	Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
title_sort	Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
dc.creator.fl_str_mv	Abbafati, Cristiana Abbas, Kaja M. Abbasi, Mohammad Abbasifard, Mitra Abbasi-Kangevari, Mohsen Abbastabar, Hedayat Abd-Allah, Foad Abdelalim, Ahmed Abdollahi, Mohammad Abdollahpour, Ibrahim
dc.contributor.author.spa.fl_str_mv	Abbafati, Cristiana Abbas, Kaja M. Abbasi, Mohammad Abbasifard, Mitra Abbasi-Kangevari, Mohsen Abbastabar, Hedayat Abd-Allah, Foad Abdelalim, Ahmed Abdollahi, Mohammad Abdollahpour, Ibrahim
dc.subject.spa.fl_str_mv	Risk-factors Clinical-trials Prevention Disability Dementia Falls
topic	Risk-factors Clinical-trials Prevention Disability Dementia Falls
description	Abbafati, Cristiana
publishDate	2020
dc.date.issued.none.fl_str_mv	2020
dc.date.accessioned.none.fl_str_mv	2021-02-05T23:11:02Z
dc.date.available.none.fl_str_mv	2021-02-05T23:11:02Z
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.content.spa.fl_str_mv	Text
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.redcol.spa.fl_str_mv	http://purl.org/redcol/resource_type/ART
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/acceptedVersion
format	http://purl.org/coar/resource_type/c_6501
status_str	acceptedVersion
dc.identifier.issn.spa.fl_str_mv	0140-6736 1474-547X
dc.identifier.uri.spa.fl_str_mv	https://hdl.handle.net/11323/7832
dc.identifier.instname.spa.fl_str_mv	Corporación Universidad de la Costa
dc.identifier.reponame.spa.fl_str_mv	REDICUC - Repositorio CUC
dc.identifier.repourl.spa.fl_str_mv	https://repositorio.cuc.edu.co/
identifier_str_mv	0140-6736 1474-547X Corporación Universidad de la Costa REDICUC - Repositorio CUC
url	https://hdl.handle.net/11323/7832 https://repositorio.cuc.edu.co/
dc.language.iso.none.fl_str_mv	eng
language	eng
dc.relation.references.spa.fl_str_mv	1 Kyu HH, Abate D, Abate KH, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1859–922. 2 James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1789–858. 3 Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1736–88. 4 WHO. Third United Nations high-level meeting on NCDs. 2018. http://www.who.int/ncds/governance/third-un-meeting/en (accessed May 17, 2018). 5 WHO. Action plan for the prevention and control of noncommunicable diseases in the WHO European Region. Copenhagen: WHO Regional Office for Europe, 2016. 6 Vayena E, Dzenowagis J, Brownstein JS, Sheikh A. Policy implications of big data in the health sector. Bull World Health Organ 2018; 96: 66–68. 7 United Nations General Assembly. Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases. New York: United Nations, 2018. 8 Stevens GA, Alkema L, Black RE, et al. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet 2016; 388: e19–23. 9 WHO. International Classification of Diseases (ICD). 2018. http://www.who.int/classifications/icd/en (accessed Feb 25, 2020). 10 Rudd K, Johnson S, Agesa K, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017. Lancet 2020; 395: 200–11. 11 Fullman N, Yearwood J, Abay SM, et al. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet 2018; 391: 2236–71. 12 Afshin A, Sur PJ, Fay KA, et al. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 2019; 393: 1958–72. 13 GBD 2019 Demographics Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1160–203. 14 Jones GH, Bruera E, Abdi S, Kantarjian HM. The opioid epidemic in the United States—overview, origins, and potential solutions. Obstet Gynecol Surv 2019; 74: 278. 15 Lyden J, Binswanger IA. The United States opioid epidemic. Semin Perinatol 2019; 43: 123–31. 16 National Institute on Drug Abuse. Opioid overdose crisis. February, 2020. https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis (accessed Feb 21, 2020). 17 Public Health Agency of Canada. Apparent opioid-related deaths in Canada. December, 2019. https://health-infobase.canada.ca/substance-related-harms/opioids/ (accessed Dec 3, 2019). 18 Soliman G, Elzalabany MS, Hassanein T, Miller FD. Mass screening for hepatitis B and C in Southern Upper Egypt. BMC Public Health 2019; 19: 1326. 19 Abdel-Razek W, Hassany M, Kabil K, et al. The world’s largest hepatitis C screening program in Egypt. 2019. https://www.postersessiononline.eu/173580348_eu/congresos/ILC2019/aula/-LBP_8_ILC2019.pdf (accessed Nov 1, 2019). 20 Omran D, Alboraie M, Zayed RA, et al. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations. World J Gastroenterol 2018; 24: 4330–40. 21 Elgharably A, Gomaa AI, Crossey MM, Norsworthy PJ, Waked I, Taylor-Robinson SD. Hepatitis C in Egypt—past, present, and future. Int J Gen Med 2016; 10: 1–6. 22 Rao MR, Naficy AB, Darwish MA, et al. Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt. BMC Infect Dis 2002; 2: 29. 23 Plotzker RE, Murphy RD, Stoltey JE. Congenital syphilis prevention: strategies, evidence, and future directions. Sex Transm Dis 2018; 45 (suppl 1): S29–37. 24 Korenromp EL, Rowley J, Alonso M, et al. Global burden of maternal and congenital syphilis and associated adverse birth outcomes—estimates for 2016 and progress since 2012. PLoS One 2019; 14: e0211720. 25 Vollset S, Goren E, Yuan C-W, et al. Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study. Lancet 2020; 396: 1285–306. 26 Ferrari AJ, Norman RE, Freedman G, et al. The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the Global Burden of Disease Study 2010. PLoS One 2014; 9: e91936. 27 Sha F, Chang Q, Law YW, Hong Q, Yip PSF. Suicide rates in China, 2004–2014: comparing data from two sample-based mortality surveillance systems. BMC Public Health 2018; 18: 239. 28 Sha F, Yip PSF, Law YW. Decomposing change in China’s suicide rate, 1990–2010: ageing and urbanisation. Inj Prev 2017; 23: 40–45. 29 Mew EJ, Padmanathan P, Konradsen F, et al. The global burden of fatal self-poisoning with pesticides 2006–15: systematic review. J Affect Disord 2017; 219: 93–104. 30 Hogan MF, Grumet JG. Suicide prevention: an emerging priority for health care. Health Aff (Millwood) 2016; 35: 1084–90. 31 WHO, UNAIDS. Progress on global access to HIV antiretroviral therapy. Geneva: World Health Organization, 2006. 32 Stover J, Bollinger L, Izazola JA, Loures L, DeLay P, Ghys PD. What is required to end the AIDS epidemic as a public health threat by 2030? The cost and impact of the fast-track approach. PLoS One 2016; 11: e0154893. 33 Steiner TJ, Stovner LJ, Vos T. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain 2016; 17: 104. 34 Lopez AD, Adair T. Is the long-term decline in cardiovasculardisease mortality in high-income countries over? Evidence from national vital statistics. Int J Epidemiol 2019; 48: 1815–23. 35 Leong DP, Joseph PG, McKee M, et al. Reducing the global burden of cardiovascular disease, part 2. Circ Res 2017; 121: 695–710. 36 GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1223–49. 37 Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol 2018; 17: 83. 38 Engelen SE, van der Graaf Y, Stam-Slob MC, et al. Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes. Int J Cardiol 2017; 248: 301–07. 39 Harries AD, Lin Y, Kumar AMV, et al. What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030? F1000Res 2018; 7: F1000 Faculty Rev-1011. 40 Suthar AB, Zachariah R, Harries AD. Ending tuberculosis by 2030: can we do it? Int J Tuberc Lung Dis 2016; 20: 1148–54. 41 WHO. Global tuberculosis report 2019. Geneva: World Health Organization, 2019. 42 Ene-Iordache B, Perico N, Bikbov B, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health 2016; 4: e307–19. 43 Stanifer JW, Isenburg MV, Chertow GM, Anand S. Chronic kidney disease care models in low- and middle-income countries: a systematic review. BMJ Glob Health 2018; 3: e000728. 44 Rehm J, Crépault J-F, Hasan OSM, Lachenmeier DW, Room R, Sornpaisarn B. Regulatory policies for alcohol, other psychoactive substances and addictive behaviours: the role of level of use and potency. A systematic review. Int J Environ Res Public Health 2019; 16: 3749. 45 Lin FR. Time for a top-down approach to hearing aid affordability and accessibility. Am J Public Health 2018; 108: 166–68. 46 Cummings J, Lee G, Ritter A, Zhong K. Alzheimer’s disease drug development pipeline: 2018. Alzheimers Dement (NY) 2018; 4: 195–214. 47 Larsson SC, Markus HS. Does treating vascular risk factors prevent dementia and Alzheimer’s disease? A systematic review and meta-analysis. J Alzheimers Dis 2018; 64: 657–68. 48 Yaffe K. Modifiable risk factors and prevention of dementia: what is the latest evidence? JAMA Intern Med 2018; 178: 281–82. 49 Brasure M, Desai P, Davila H, et al. Physical activity interventions in preventing cognitive decline and Alzheimer-type dementia: a systematic review. Ann Intern Med 2018; 168: 30. 50 Seppala LJ, van de Glind EMM, Daams JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: III. Others. J Am Med Dir Assoc 2018; 19: 372.e1–8. 51 Xu T, Clemson L, O’Loughlin K, Lannin NA, Dean C, Koh G. Risk factors for falls in community stroke survivors: a systematic review and meta-analysis. Arch Phys Med Rehabil 2018; 99: 563–73.e5. 52 Lan X, Li H, Wang Z, Chen Y. Frailty as a predictor of future falls in hospitalized patients: A systematic review and meta-analysis. Geriatr Nur 2019; published online Feb 11. DOI:10.1016/j.gerinurse.2019.01.004. 53 Cheng P, Tan L, Ning P, et al. Comparative effectiveness of published interventions for elderly fall prevention: a systematic review and network meta-analysis. Int J Environ Res Public Health 2018; 15: 498. 54 WHO. Noncommunicable diseases. June 1, 2018. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases(accessed Jan 27, 2020). 55 Nugent R, Bertram MY, Jan S, et al. Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals. Lancet 2018; 391: 2029–35. 56 Cottingham MD, Kalbaugh CA, Fisher JA. Tracking the pharmaceutical pipeline: clinical trials and global disease burden. Clin Transl Sci 2014; 7: 297–99. 57 Fisher JA, Cottingham MD, Kalbaugh CA. Peering into the pharmaceutical “pipeline”: investigational drugs, clinical trials, and industry priorities. Soc Sci Med 2015; 131: 322–30. 58 Long G. The biopharmaceutical pipeline: innovative therapies in clinical development. Boston, MA: Analysis Group, 2017. 59 Singh GK, Siahpush M, Azuine RE, Williams SD. Increasing area deprivation and socioeconomic inequalities in heart disease, stroke, and cardiovascular disease mortality among working age populations, United States, 1969–2011. Int J MCH AIDS 2015; 3: 119–33. 60 Schultze-Kraft M, Chinchilla FA, Moriconi M. New perspectives on crime, violence and insecurity in Latin America. Crime Law Soc Change 2018; 69: 465–73.
dc.rights.spa.fl_str_mv	CC0 1.0 Universal
dc.rights.uri.spa.fl_str_mv	http://creativecommons.org/publicdomain/zero/1.0/
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	CC0 1.0 Universal http://creativecommons.org/publicdomain/zero/1.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Corporación Universidad de la Costa
dc.source.spa.fl_str_mv	The Lancet
institution	Corporación Universidad de la Costa
dc.source.url.spa.fl_str_mv	https://www.sciencedirect.com/science/article/pii/S147444221830454X
bitstream.url.fl_str_mv	https://repositorio.cuc.edu.co/bitstreams/eb7dc075-d115-488d-8e31-d3f2c9812359/download https://repositorio.cuc.edu.co/bitstreams/7bd0c73d-3b3e-4a13-8cb0-68e5ce1a0c16/download https://repositorio.cuc.edu.co/bitstreams/5c4fe9b6-6767-4984-b2f9-34f78294dc88/download https://repositorio.cuc.edu.co/bitstreams/53052d0c-bd9e-4c8f-9e4c-e09edc9bc3c9/download https://repositorio.cuc.edu.co/bitstreams/e83136e4-e6ec-4747-933e-088c70ec3ef9/download
bitstream.checksum.fl_str_mv	5b5fc6e3b378752c3a3912dd7164ac13 42fd4ad1e89814f5e4a476b409eb708c e30e9215131d99561d40d6b0abbe9bad 94432fe241ae8f7beb93f7520a8c18d3 06da9f182fab6b385a75ddf177c35488
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5 MD5 MD5 MD5
repository.name.fl_str_mv	Repositorio de la Universidad de la Costa CUC
repository.mail.fl_str_mv	repdigital@cuc.edu.co
_version_	1828166898679808000
spelling	Abbafati, CristianaAbbas, Kaja M.Abbasi, MohammadAbbasifard, MitraAbbasi-Kangevari, MohsenAbbastabar, HedayatAbd-Allah, FoadAbdelalim, AhmedAbdollahi, MohammadAbdollahpour, Ibrahim2021-02-05T23:11:02Z2021-02-05T23:11:02Z20200140-67361474-547Xhttps://hdl.handle.net/11323/7832Corporación Universidad de la CostaREDICUC - Repositorio CUChttps://repositorio.cuc.edu.co/application/pdfengCorporación Universidad de la CostaCC0 1.0 Universalhttp://creativecommons.org/publicdomain/zero/1.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2The Lancethttps://www.sciencedirect.com/science/article/pii/S147444221830454XRisk-factorsClinical-trialsPreventionDisabilityDementiaFallsGlobal burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019Artículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/acceptedVersion1 Kyu HH, Abate D, Abate KH, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1859–922.2 James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1789–858.3 Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1736–88.4 WHO. Third United Nations high-level meeting on NCDs. 2018. http://www.who.int/ncds/governance/third-un-meeting/en (accessed May 17, 2018).5 WHO. Action plan for the prevention and control of noncommunicable diseases in the WHO European Region. Copenhagen: WHO Regional Office for Europe, 2016.6 Vayena E, Dzenowagis J, Brownstein JS, Sheikh A. Policy implications of big data in the health sector. Bull World Health Organ 2018; 96: 66–68.7 United Nations General Assembly. Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases. New York: United Nations, 2018.8 Stevens GA, Alkema L, Black RE, et al. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet 2016; 388: e19–23.9 WHO. International Classification of Diseases (ICD). 2018. http://www.who.int/classifications/icd/en (accessed Feb 25, 2020).10 Rudd K, Johnson S, Agesa K, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017. Lancet 2020; 395: 200–11.11 Fullman N, Yearwood J, Abay SM, et al. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet 2018; 391: 2236–71.12 Afshin A, Sur PJ, Fay KA, et al. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 2019; 393: 1958–72.13 GBD 2019 Demographics Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1160–203.14 Jones GH, Bruera E, Abdi S, Kantarjian HM. The opioid epidemic in the United States—overview, origins, and potential solutions. Obstet Gynecol Surv 2019; 74: 278.15 Lyden J, Binswanger IA. The United States opioid epidemic. Semin Perinatol 2019; 43: 123–31.16 National Institute on Drug Abuse. Opioid overdose crisis. February, 2020. https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis (accessed Feb 21, 2020).17 Public Health Agency of Canada. Apparent opioid-related deaths in Canada. December, 2019. https://health-infobase.canada.ca/substance-related-harms/opioids/ (accessed Dec 3, 2019).18 Soliman G, Elzalabany MS, Hassanein T, Miller FD. Mass screening for hepatitis B and C in Southern Upper Egypt. BMC Public Health 2019; 19: 1326.19 Abdel-Razek W, Hassany M, Kabil K, et al. The world’s largest hepatitis C screening program in Egypt. 2019. https://www.postersessiononline.eu/173580348_eu/congresos/ILC2019/aula/-LBP_8_ILC2019.pdf (accessed Nov 1, 2019).20 Omran D, Alboraie M, Zayed RA, et al. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations. World J Gastroenterol 2018; 24: 4330–40.21 Elgharably A, Gomaa AI, Crossey MM, Norsworthy PJ, Waked I, Taylor-Robinson SD. Hepatitis C in Egypt—past, present, and future. Int J Gen Med 2016; 10: 1–6.22 Rao MR, Naficy AB, Darwish MA, et al. Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt. BMC Infect Dis 2002; 2: 29.23 Plotzker RE, Murphy RD, Stoltey JE. Congenital syphilis prevention: strategies, evidence, and future directions. Sex Transm Dis 2018; 45 (suppl 1): S29–37.24 Korenromp EL, Rowley J, Alonso M, et al. Global burden of maternal and congenital syphilis and associated adverse birth outcomes—estimates for 2016 and progress since 2012. PLoS One 2019; 14: e0211720.25 Vollset S, Goren E, Yuan C-W, et al. Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study. Lancet 2020; 396: 1285–306.26 Ferrari AJ, Norman RE, Freedman G, et al. The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the Global Burden of Disease Study 2010. PLoS One 2014; 9: e91936.27 Sha F, Chang Q, Law YW, Hong Q, Yip PSF. Suicide rates in China, 2004–2014: comparing data from two sample-based mortality surveillance systems. BMC Public Health 2018; 18: 239.28 Sha F, Yip PSF, Law YW. Decomposing change in China’s suicide rate, 1990–2010: ageing and urbanisation. Inj Prev 2017; 23: 40–45.29 Mew EJ, Padmanathan P, Konradsen F, et al. The global burden of fatal self-poisoning with pesticides 2006–15: systematic review. J Affect Disord 2017; 219: 93–104.30 Hogan MF, Grumet JG. Suicide prevention: an emerging priority for health care. Health Aff (Millwood) 2016; 35: 1084–90.31 WHO, UNAIDS. Progress on global access to HIV antiretroviral therapy. Geneva: World Health Organization, 2006.32 Stover J, Bollinger L, Izazola JA, Loures L, DeLay P, Ghys PD. What is required to end the AIDS epidemic as a public health threat by 2030? The cost and impact of the fast-track approach. PLoS One 2016; 11: e0154893.33 Steiner TJ, Stovner LJ, Vos T. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain 2016; 17: 104.34 Lopez AD, Adair T. Is the long-term decline in cardiovasculardisease mortality in high-income countries over? Evidence from national vital statistics. Int J Epidemiol 2019; 48: 1815–23.35 Leong DP, Joseph PG, McKee M, et al. Reducing the global burden of cardiovascular disease, part 2. Circ Res 2017; 121: 695–710.36 GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1223–49.37 Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol 2018; 17: 83.38 Engelen SE, van der Graaf Y, Stam-Slob MC, et al. Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes. Int J Cardiol 2017; 248: 301–07.39 Harries AD, Lin Y, Kumar AMV, et al. What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030? F1000Res 2018; 7: F1000 Faculty Rev-1011.40 Suthar AB, Zachariah R, Harries AD. Ending tuberculosis by 2030: can we do it? Int J Tuberc Lung Dis 2016; 20: 1148–54.41 WHO. Global tuberculosis report 2019. Geneva: World Health Organization, 2019.42 Ene-Iordache B, Perico N, Bikbov B, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health 2016; 4: e307–19.43 Stanifer JW, Isenburg MV, Chertow GM, Anand S. Chronic kidney disease care models in low- and middle-income countries: a systematic review. BMJ Glob Health 2018; 3: e000728.44 Rehm J, Crépault J-F, Hasan OSM, Lachenmeier DW, Room R, Sornpaisarn B. Regulatory policies for alcohol, other psychoactive substances and addictive behaviours: the role of level of use and potency. A systematic review. Int J Environ Res Public Health 2019; 16: 3749.45 Lin FR. Time for a top-down approach to hearing aid affordability and accessibility. Am J Public Health 2018; 108: 166–68.46 Cummings J, Lee G, Ritter A, Zhong K. Alzheimer’s disease drug development pipeline: 2018. Alzheimers Dement (NY) 2018; 4: 195–214.47 Larsson SC, Markus HS. Does treating vascular risk factors prevent dementia and Alzheimer’s disease? A systematic review and meta-analysis. J Alzheimers Dis 2018; 64: 657–68.48 Yaffe K. Modifiable risk factors and prevention of dementia: what is the latest evidence? JAMA Intern Med 2018; 178: 281–82.49 Brasure M, Desai P, Davila H, et al. Physical activity interventions in preventing cognitive decline and Alzheimer-type dementia: a systematic review. Ann Intern Med 2018; 168: 30.50 Seppala LJ, van de Glind EMM, Daams JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: III. Others. J Am Med Dir Assoc 2018; 19: 372.e1–8.51 Xu T, Clemson L, O’Loughlin K, Lannin NA, Dean C, Koh G. Risk factors for falls in community stroke survivors: a systematic review and meta-analysis. Arch Phys Med Rehabil 2018; 99: 563–73.e5.52 Lan X, Li H, Wang Z, Chen Y. Frailty as a predictor of future falls in hospitalized patients: A systematic review and meta-analysis. Geriatr Nur 2019; published online Feb 11. DOI:10.1016/j.gerinurse.2019.01.004.53 Cheng P, Tan L, Ning P, et al. Comparative effectiveness of published interventions for elderly fall prevention: a systematic review and network meta-analysis. Int J Environ Res Public Health 2018; 15: 498.54 WHO. Noncommunicable diseases. June 1, 2018. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases(accessed Jan 27, 2020).55 Nugent R, Bertram MY, Jan S, et al. Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals. Lancet 2018; 391: 2029–35.56 Cottingham MD, Kalbaugh CA, Fisher JA. Tracking the pharmaceutical pipeline: clinical trials and global disease burden. Clin Transl Sci 2014; 7: 297–99.57 Fisher JA, Cottingham MD, Kalbaugh CA. Peering into the pharmaceutical “pipeline”: investigational drugs, clinical trials, and industry priorities. Soc Sci Med 2015; 131: 322–30.58 Long G. The biopharmaceutical pipeline: innovative therapies in clinical development. Boston, MA: Analysis Group, 2017.59 Singh GK, Siahpush M, Azuine RE, Williams SD. Increasing area deprivation and socioeconomic inequalities in heart disease, stroke, and cardiovascular disease mortality among working age populations, United States, 1969–2011. Int J MCH AIDS 2015; 3: 119–33.60 Schultze-Kraft M, Chinchilla FA, Moriconi M. New perspectives on crime, violence and insecurity in Latin America. Crime Law Soc Change 2018; 69: 465–73.Abbafati, CristianaAbbas, Kaja M.Abbasi, MohammadAbbasifard, MitraAbbasi-Kangevari, MohsenAbbastabar, HedayatAbd-Allah, FoadAbdelalim, AhmedAbdollahi, MohammadAbdollahpour, IbrahimPublicationORIGINALGlobal burden of 369 diseases and injuries in 204 countries.pdfGlobal burden of 369 diseases and injuries in 204 countries.pdfapplication/pdf1927952https://repositorio.cuc.edu.co/bitstreams/eb7dc075-d115-488d-8e31-d3f2c9812359/download5b5fc6e3b378752c3a3912dd7164ac13MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8701https://repositorio.cuc.edu.co/bitstreams/7bd0c73d-3b3e-4a13-8cb0-68e5ce1a0c16/download42fd4ad1e89814f5e4a476b409eb708cMD52LICENSElicense.txtlicense.txttext/plain; charset=utf-83196https://repositorio.cuc.edu.co/bitstreams/5c4fe9b6-6767-4984-b2f9-34f78294dc88/downloade30e9215131d99561d40d6b0abbe9badMD53THUMBNAILGlobal burden of 369 diseases and injuries in 204 countries.pdf.jpgGlobal burden of 369 diseases and injuries in 204 countries.pdf.jpgimage/jpeg76697https://repositorio.cuc.edu.co/bitstreams/53052d0c-bd9e-4c8f-9e4c-e09edc9bc3c9/download94432fe241ae8f7beb93f7520a8c18d3MD54TEXTGlobal burden of 369 diseases and injuries in 204 countries.pdf.txtGlobal burden of 369 diseases and injuries in 204 countries.pdf.txttext/plain124335https://repositorio.cuc.edu.co/bitstreams/e83136e4-e6ec-4747-933e-088c70ec3ef9/download06da9f182fab6b385a75ddf177c35488MD5511323/7832oai:repositorio.cuc.edu.co:11323/78322024-09-17 14:23:39.046http://creativecommons.org/publicdomain/zero/1.0/CC0 1.0 Universalopen.accesshttps://repositorio.cuc.edu.coRepositorio de la Universidad de la Costa CUCrepdigital@cuc.edu.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

Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

Publicaciones similares